← Leaderboards
David Reboussin
Wake Forest University Health Sciences
$26,999,221
Attributed
$26,999,221
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.4M · FY2011–17$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$26,999,221 · 1
By mechanism
N01$26,999,221 · 1
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Barry Ira Freedman$20,046,491
- Christos Constantinidis$16,351,088
- Jeff Douglas Williamson$16,761,474
- Scott D Rhodes$18,418,079
- Chadwick David Miller$4,944,032
Others in their field
Top investigators on “Acute Coronary Syndrome”
- Judith S Hochman · New York University School Of Medicine$113,079,687
- Walter N Kernan · Yale University$42,197,025
- Karen P Alexander · Duke University$28,401,535
- Harry P Selker · Virginia Commonwealth University$21,988,329
- Karina W. Davidson · Mount Sinai School Of Medicine Of Nyu$21,109,995
- Walter T Ambrosius · Indiana Univ-Purdue Univ At Indianapolis$20,997,388
Research focus
Acute Coronary SyndromeAge-Associated Memory ImpairmentAgedBlood PressureCardiovascular DiseasesCardiovascular Disorder RiskCerebrumCessation Of LifeChronic Kidney FailureClinicRisk FactorsSecondary OutcomeStrokeTreatment ProgramCognitive FunctionDementiaEnd Stage Renal FailureHeart FailureIntervention TrialKidney DiseasesMortality DeclineMyocardial InfarctionParticipantPrimary Outcome
Grant awards (7)
OTHER FUNCTIONS R&D, SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT) COORDIN$3,532,369
N01 · FY2017 · HL · contact PI
OTHER FUNCTIONS R&D, SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT) COORDINATING CENTER$297,000
N01 · FY2017 · HL · contact PI
OTHER FUNCTIONS R&D, SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT) COORDIN$5,341,073
N01 · FY2016 · HL · contact PI
OTHER FUNCTIONS R&D, SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT) COORDIN$6,158,999
N01 · FY2015 · HL · contact PI
OTHER FUNCTIONS R&D, SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT) COORDIN$6,395,137
N01 · FY2014 · HL · contact PI
OTHER FUNCTIONS R&D, SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT) COORDIN$5,234,260
N01 · FY2013 · HL · contact PI
BIOMEDICAL (BASIC) Systolic Blood Pressure Intervention Trial (SPRINT)$40,383
N01 · FY2011 · HL · contact PI